Turkiye Klinikleri Journal of Health Sciences

.: REVIEW
Depresyonda Beslenmeye Farklı Bir Bakış: Fizyopatolojik Yolaklar Üzerinde Besin Ögelerinin Önemi
A Different View of Nutrition in Depression: The Importance of Nutrients on Physiopathological Pathways
Emine KURTBEYOĞLUa, Gül AKDUMANb, Fatma Esra GÜNEŞb
aErciyes Üniversitesi Sağlık Bilimleri Enstitüsü, Beslenme ve Diyetetik ABD, Kayseri, TÜRKİYE
bMarmara Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik ABD, İstanbul, TÜRKİYE
Turkiye Klinikleri J Health Sci. 2021;6(2):320-8
doi: 10.5336/healthsci.2020-76016
Article Language: TR
Full Text
ÖZET
 Beslenme; hormonal yolakları, nörotransmitterleri ve sinyal yolaklarını aktive ederek iştah, uyku, enerji alımı, nörojenez, ödül mekanizmaları, bilişsel işlev ve ruh hâli gibi beyin fonksiyonlarını düzenlemektedir. Kronik olarak strese bağlı bozukluklarda tekrar yeme davranışının modüle olabildiği tespit edilmiştir. Bununla birlikte, bazı besin ögeleri strese bağlı bozuklukları tetikleyebilmektedir. Yapılan araştırmalarda; folat, omega-3 yağ asitleri, tekli doymamış yağ asitleri, zeytinyağı, balık tüketimi, meyveler, sebzeler, fındıklar ve baklagiller bakımından zengin bir diyetin, azalmış depresyon riski ile ilişkili olduğu gösterilmiştir. B grubu vitaminler ile D vitamini antioksidan yolaklar ve nörotransmitter yolaklar üzerindeki etkisi ile depresif semptomların önlenmesinde önemlidir. Buna karşılık yapılan diğer araştırmalarda; şekerli içecekler, rafine gıdalar, kızarmış yiyecekler, işlenmiş et, rafine tahıllar ve yağ oranı yüksek süt ürünleri, bisküvi, meze ve hamur işi tüketimini kapsayan sağlıksız batı tarzı beslenme alışkanlıklarının, artmış depresyon riski ile ilişkili olduğu gösterilmiştir. Sonuç olarak, besinlerin ve beslenme şeklinin depresyon gibi psikiyatrik sorunların tedavisinde rol oynayabileceği giderek yaygın bir görüş hâline gelmektedir.

Anahtar Kelimeler: Depresyon; fizyopatoloji; mineraller; vitaminler
ABSTRACT
 Nutrition regulates hormonal pathways, neurotransmitters and signal pathways, and regulates brain functions such as appetite, sleep, energy intake, neurogenesis, reward mechanisms, cognitive function and mood. It has been determined that repeat eating behavior can be modulated in chronic stress related disorders. However, some nutrients can trigger stress-related disorders. Studies have shown that folate, omega-3 fatty acids, monounsaturated fatty acids, olive oil, and fish consumption and a diet rich in fruits, vegetables, nuts, and legumes are associated with reduced risk of depression. Vitamin B and vitamin D are important in preventing depressive symptoms with their effects on antioxidant pathways and neurotransmitter pathways. In contrast, other studies have shown that unhealthy western-style eating habits, including sugary drinks, refined foods, fried foods, processed meat, refined grains, and high-fat dairy products, biscuits, appetizers, and pastries, are associated with an increased risk of depression. As a result, it is becoming an increasingly common view that nutrients and diet can play a role in the treatment of psychiatric problems such as depression.

Keywords: Depression; physiopathology; minerals; vitamins
REFERENCES:
  1. Khosravi M, Sotoudeh G, Amini M, Raisi F, Mansoori A, Hosseinzadeh M. The relationship between dietary patterns and depression mediated by serum levels of Folate and vitamin B12. BMC Psychiatry. 2020;20(1):63. [Crossref]  [PubMed]  [PMC] 
  2. WHO. World Health Organization. (Erişim tarihi: 30.6.2020) [Crossref] 
  3. Özenoğlu A. [Relationship between mood, food and nutrition]. ACU Sağlık Bil Derg. 2018;9(4):357-65. [Link] 
  4. Jacka FN, Mykletun A, Berk M, Bjelland I, Tell GS. The association between habitual diet quality and the common mental disorders in community-dwelling adults: the Hordaland Health study. Psychosom Med. 2011;73(6):483-90. [Crossref]  [PubMed] 
  5. Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional aspects of depression. Cell Physiol Biochem. 2015;37(3):1029-43. [Crossref]  [PubMed] 
  6. Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31(6):761-77. [Crossref]  [PubMed] 
  7. Linares DM, Martín MC, Ladero V, Alvarez MA, Fernández M. Biogenic amines in dairy products. Crit Rev Food Sci Nutr. 2011;51(7):691-703. [Crossref]  [PubMed] 
  8. Shan L, Qi XR, Balesar R, Swaab DF, Bao AM. Unaltered histaminergic system in depression: a postmortem study. J Affect Disord. 2013;146(2):220-3. [Crossref]  [PubMed] 
  9. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry. 2000;157(5):715-21. [Crossref]  [PubMed] 
  10. Elstgeest LE, Brouwer IA, Penninx BW, van Schoor NM, Visser M. Vitamin B12, homocysteine and depressive symptoms: a longitudinal study among older adults. Eur J Clin Nutr. 2017;71(4):468-75. [Crossref]  [PubMed] 
  11. Kano M, Fukudo S, Tashiro A, Utsumi A, Tamura D, Itoh M, et al. Decreased histamine H1 receptor binding in the brain of depressed patients. Eur J Neurosci. 2004;20(3):803-10. [Crossref]  [PubMed] 
  12. Deng C, Weston-Green K, Huang XF. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(1):1-4. [Crossref]  [PubMed] 
  13. Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 2010;30(3):273-81. [Crossref]  [PubMed] 
  14. Do KQ, Conus P, Cuenod M. Redox dysregulation and oxidative stress in schizophrenia: nutrigenetics as a challenge in psychiatric disease prevention. J Nutrigenet Nutrigenomics. 2010;3(4-6):267-89. [Crossref]  [PubMed] 
  15. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207-22. [Crossref]  [PubMed] 
  16. Jiang X, Xu L, Tang L, Liu F, Chen Z, Zhang J, et al. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model. J Neuroinflammation. 2018;15(1):3. [Crossref]  [PubMed]  [PMC] 
  17. Azmitia EC. Evolution of serotonin: sunlight to suicide. Handbook of Behavioral Neuroscience. 2010;21:3-22. [Crossref] 
  18. Dantzer R, O'Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426-36. [Crossref]  [PubMed]  [PMC] 
  19. Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature. 2013;493(7433):537-41. [Crossref]  [PubMed]  [PMC] 
  20. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature. 2013;493(7433):532-6. [Crossref]  [PubMed]  [PMC] 
  21. Smith KJ, Sanderson K, McNaughton SA, Gall SL, Dwyer T, Venn AJ. Longitudinal associations between fish consumption and depression in young adults. Am J Epidemiol. 2014;179(10):1228-35. [Crossref]  [PubMed] 
  22. Moret C, Briley M. The importance of norepinephrine in depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):9-13. [Crossref]  [PubMed]  [PMC] 
  23. Márquez-Gómez R, García-Gálvez AM, Morales-Figueroa GE, Arias-Monta-o JA. Modulation by histamine H3 receptors of neurotransmitter release in the basal ganglia. In: Blandina P, Passani MB, eds. Histamine Receptors. 1st ed. Switzerland: Springer International Publishing; 2016. p.265-93. [Crossref] 
  24. Deacon G, Kettle C, Hayes D, Dennis C, Tucci J. Omega 3 polyunsaturated fatty acids and the treatment of depression. Crit Rev Food Sci Nutr. 2017;57(1):212-23. [Crossref]  [PubMed] 
  25. Sanhueza C, Ryan L, Foxcroft DR. Diet and the risk of unipolar depression in adults: systematic review of cohort studies. J Hum Nutr Diet. 2013;26(1):56-70. [Crossref]  [PubMed] 
  26. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84. [Crossref]  [PubMed] 
  27. Kyrou I, Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol. 2009;9(6):787-93. [Crossref]  [PubMed] 
  28. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci. 2006;1083:77-110. [Crossref]  [PubMed] 
  29. Choi KW, Na EJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder. Psychiatry Res. 2018;270:246-52. [Crossref]  [PubMed] 
  30. Kyrou I, Tsigos C. Stress mechanisms and metabolic complications. Horm Metab Res. 2007;39(6):430-8. [Crossref]  [PubMed] 
  31. Sinha R. Role of addiction and stress neurobiology on food intake and obesity. Biol Psychol. 2018;131:5-13. [Crossref]  [PubMed]  [PMC] 
  32. Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology. 2011;36(12):2375-94. [Crossref]  [PubMed]  [PMC] 
  33. Clays E, De Bacquer D, Delanghe J, Kittel F, Van Renterghem L, De Backer G. Associations between dimensions of job stress and biomarkers of inflammation and infection. J Occup Environ Med. 2005;47(9):878-83. [Crossref]  [PubMed] 
  34. Sominsky L, Spencer SJ. Eating behavior and stress: a pathway to obesity. Front Psychol. 2014;5:434. [Crossref]  [PubMed]  [PMC] 
  35. Kirkegaard C, Faber J. The role of thyroid hormones in depression. Eur J Endocrinol. 1998;138(1):1-9. [Crossref]  [PubMed] 
  36. Gangwisch JE, Hale L, Garcia L, Malaspina D, Opler MG, Payne ME,et al. High glycemic index diet as a risk factor for depression: analyses from the Women's Health Initiative. Am J Clin Nutr. 2015;102(2):454-63. [Crossref]  [PubMed]  [PMC] 
  37. Sanchez-Villegas A, Zazpe I, Santiago S, Perez-Cornago A, Martinez-Gonzalez MA, Lahortiga-Ramos F. Added sugars and sugar-sweetened beverage consumption, dietary carbohydrate index and depression risk in the Seguimiento Universidad de Navarra (SUN) Project. Br J Nutr. 2018;119(2):211-21. [Crossref]  [PubMed] 
  38. Shi H, Wang B, Xu X. Antidepressant effect of vitamin d: a literature review. Neuropsychiatry (London). 2017;7(4):337-41. [Link] 
  39. Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health. 2014;14:56. [Crossref]  [PubMed]  [PMC] 
  40. Petrilli MA, Kranz TM, Kleinhaus K, Joe P, Getz M, Johnson P, et al. The emerging role for zinc in depression and psychosis. front pharmacol. 2017;8:414. [Crossref]  [PubMed]  [PMC] 
  41. Wang J, Um P, Dickerman BA, Liu J. Zinc, magnesium, selenium and depression: a review of the evidence, potential mechanisms and implications. Nutrients. 2018;10(5):584. [Crossref]  [PubMed]  [PMC] 
  42. Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz MA, et al. Dietary selenium and major depression: a nested case-control study. Complement Ther Med. 2012;20(3):119-23. [Crossref]  [PubMed] 
  43. Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS One. 2017;12(6):e0180067. [Crossref]  [PubMed]  [PMC] 
  44. Stanisławska M, Szkup-Jabłońska M, Jurczak A, Wieder-Huszla S, Samochowiec A, Jasiewicz A, et al. The severity of depressive symptoms vs. serum Mg and Zn levels in postmenopausal women. Biol Trace Elem Res. 2014;157(1):30-5. [Crossref]  [PubMed]  [PMC] 
  45. Zhang R, Sun J, Li Y, Zhang D. Associations of n-3, n-6 fatty acids intakes and n-6:n-3 ratio with the risk of depressive symptoms: NHANES 2009-2016. Nutrients. 2020;12(1):240. [Crossref]  [PubMed]  [PMC] 
  46. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13(4):267-71. Erratum in: Eur Neuropsychopharmacol. 2004;14(2):173. [Crossref]  [PubMed] 
  47. Yannakoulia M, Kontogianni M, Scarmeas N. Cognitive health and Mediterranean diet: just diet or lifestyle pattern? Ageing Res Rev. 2015;20:74-8. [Crossref]  [PubMed] 
  48. Olveira C, Olveira G, Espildora F, Girón RM, Vendrell M, Dorado A, et al. Mediterranean diet is associated on symptoms of depression and anxiety in patients with bronchiectasis. Gen Hosp Psychiatry. 2014;36(3):277-83. d [Crossref]  [PubMed] 
  49. Barbaresko J, Koch M, Schulze MB, Nöthlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013;71(8):511-27. [Crossref]  [PubMed] 
  50. Fragopoulou E, Panagiotakos DB, Pitsavos C, Tampourlou M, Chrysohoou C, Nomikos T, et al. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: the ATTICA study. J Nutr Biochem. 2010;21(4):285-9. [Crossref]  [PubMed] 
  51. Park Y, Park YS, Kim SH, Oh DH, Park YC. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea. Ann Nutr Metab. 2015;66(2-3):141-8. [Crossref]  [PubMed] 
  52. Taylor AM, Thompson SV, Edwards CG, Musaad SMA, Khan NA, Holscher HD. Associations among diet, the gastrointestinal microbiota, and negative emotional states in adults. Nutr Neurosci. 2020;23(12):983-92. [Crossref]  [PubMed] 
  53. Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Med. 2017;15(1):23. Erratum in: BMC Med. 2018;16(1):236. [Crossref]  [PubMed]  [PMC] 
  54. Liu X, Yan Y, Li F, Zhang D. Fruit and vegetable consumption and the risk of depression: A meta-analysis. Nutrition. 2016;32(3):296-302. [Crossref]  [PubMed] 
  55. Taylor AM, Holscher HD. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. 2020;23(3):237-50. [Crossref]  [PubMed] 
  56. Murphy AB, Dinan TG, Cryan JF, Stanton C, Ross RP. Probiotics as curators of a healthy gut microbiota: delivering the solution. In: Hyland N, Stanton C, eds. The Gut-Brain Axis: Dietary, Probiotic, and Prebiotic Interventions on the Microbiota. 1st ed. Ireland: Elseiver; 2016. p.61-88. [Crossref]  [PMC] 
  57. Kim CS, Shin DM. Probiotic food consumption is associated with lower severity and prevalence of depression: A nationwide cross-sectional study. Nutrition. 2019;63-64:169-174. [Crossref]  [PubMed] 
  58. Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, et al; BBMRI-NL Metabolomics Consortium. Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry. 2020;87(5):409-18. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com